DreamTec
DreamTec is a biotechnology group based in Hong Kong. Founded in 2018 by Dr. Keith WY Kwong and Mr. Christopher Chung, J.p. DreamTec is committed to biotechnology research, innovatively manufacturing cutting-edge products and technologies, focusing on the use of bioengineering, cell Technology and regenerative medicine research and development, with the purpose of improving human health.
Local research team
Own Hong Kong factory
Market unique product
Scientific Research Strength
DreamTec is the first biologics research center in Hong Kong that has obtained WHO GMP standard certification. There are research bases in the Hong Kong Science Park and the University of Washington in the United States.
DreamTec has cutting-edge bioengineering technology. The scientific research team led by Dr. Kuang Weiyang, the scientific director, has achieved a number of exclusive research and development results in genetic engineering, human growth factor (hEGF and hbFGF) and human stem cells and other regenerative medicine technologies, and has been distributed to the international He has published a number of scientific papers, and obtained a number of patents for technological inventions in Europe, America, China and Hong Kong.
higher cleanliness standards
International standard class dust-free clean room
Certified by the International Clean Room Environmental Testing Association.
Product SGS certification
All products have passed the safety test of SGS, a third-party verification agency, to ensure that the products can be used safely.
FDA Registered Plant
International recognition
International WHO GMP standard workshop
The first in Hong Kong
DreamTec signed a registration contract with the French International Quality Certification Center (Hong Kong) Co., Ltd. to obtain WHO GMP certification in 2020. The main areas include recombinant protein, stem cell production, health care products and repair ointments, etc.
Brand
